|
1
|
Janakiram NB and Rao CV: The role of
inflammation in colon cancer. Adv Exp Med Biol. 816:25–52. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deng M, Lan Y and Luo S: Quality of life
estimate in stomach, colon, and rectal cancer patients in a
hospital in China. Tumour Biol. 34:2809–2815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fengju S, Guanglin W and Kexin C:
Incidence of colon cancer in Tianjin, China, 1981–2000. Asia Pac J
Public Health. 17:22–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hou L, Ji BT, Blair A, Dai Q, Gao YT and
Chow WH: Commuting physical activity and risk of colon cancer in
Shanghai, China. Am J Epidemiol. 160:860–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiu BC, Ji BT, Dai Q, Gridley G,
McLaughlin JK, Gao YT, Fraumeni JF Jr and Chow WH: Dietary factors
and risk of colon cancer in Shanghai, China. Cancer Epidemiol
Biomarkers Prev. 12:201–208. 2003.PubMed/NCBI
|
|
6
|
Diao D, Wang L, Wan J, Chen Z, Peng J, Liu
H, Chen X, Wang W and Zou L: MEK5 overexpression is associated with
the occurrence and development of colorectal cancer. BMC Cancer.
16:3022016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lassmann S, Kreutz C, Schoepflin A, Hopt
U, Timmer J and Werner M: A novel approach for reliable microarray
analysis of microdissected tumor cells from formalin-fixed and
paraffin-embedded colorectal cancer resection specimens. J Mol Med
(Berl). 87:211–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Chen Y, Fu X, Zhou X, Peng Y, Shi L,
Chen T and Wu Y: Invasive Fusobacterium nucleatum may play a role
in the carcinogenesis of proximal colon cancer through the serrated
neoplasia pathway. Int J Cancer. 139:1318–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Li X, Wu M, Lin C, Guo Y and Tian
B: Knockdown of long noncoding RNA GHET1 inhibits cell
proliferation and invasion of colorectal cancer. Oncol Res.
23:303–309. 2016. View Article : Google Scholar
|
|
10
|
Ren W, Shen S, Sun Z, Shu P, Shen X, Bu C,
Ai F, Zhang X, Tang A, Tian L, et al: Jak-STAT3 pathway triggers
DICER1 for proteasomal degradation by ubiquitin ligase complex of
CUL4A(DCAF1) to promote colon cancer development. Cancer Lett.
375:209–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mullany LE, Wolff RK, Herrick JS, Buas MF
and Slattery ML: SNP regulation of microRNA expression and
subsequent colon cancer risk. PLoS One. 10:e01438942015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Xu Y, Qiu W, Zhao D and Zhang Y:
Tissue miR-193b as a novel biomarker for patients with ovarian
cancer. Med Sci Monit. 21:3929–3934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feuermann Y, Kang K, Gavrilova O,
Haetscher N, Jang SJ, Yoo KH, Jiang C, Gonzalez FJ, Robinson GW and
Hennighausen L: MiR-193b and miR-365-1 are not required for the
development and function of brown fat in the mouse. RNA Biol.
10:1807–1814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li XF, Yan PJ and Shao ZM: Downregulation
of miR-193b contributes to enhance urokinase-type plasminogen
activator (uPA) expression and tumor progression and invasion in
human breast cancer. Oncogene. 28:3937–3948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao K, Zhang J, He C, Xu K, Liu J, Sun J,
Wu G, Tan C, Zeng Y, Wang J and Xiao Z: Restoration of miR-193b
sensitizes Hepatitis B virus-associated hepatocellular carcinoma to
sorafenib. Cancer Lett. 352:245–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu H, Krasinskas A and Willis J:
Perspectives on current tumor-node-metastasis (TNM) staging of
cancers of the colon and rectum. Semin Oncol. 38:500–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiu VK, Bivona T, Hach A, Sajous JB,
Silletti J, Wiener H, Johnson RL II, Cox AD and Philips MR: Ras
signaling on the endoplasmic reticulum and the Golgi. Nat Cell
Biol. 4:343–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen H, Gao J, Du Z, Zhang X, Yang F and
Gao W: Expression of factors and key components associated with the
PI3K signaling pathway in colon cancer. Oncol Lett. 15:5465–5472.
2018.PubMed/NCBI
|
|
22
|
Wang YN, Chen ZH and Chen WC: Novel
circulating microRNAs expression profile in colon cancer: A pilot
study. Eur J Med Res. 22:512017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Du Y, Liu X, Cho WC and Yang Y:
MicroRNAs as regulator of signaling networks in metastatic colon
cancer. Biomed Res Int. 2015:8236202015.PubMed/NCBI
|
|
24
|
Li X, Qin B and Liu BO: Delineating the
effect of demethylating agent 5-aza-2′-deoxycytidine on human
Caco-2 colonic carcinoma cells. Oncol Lett. 12:139–143. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pagliara V, Saide A, Mitidieri E,
d'Emmanuele di Villa Bianca R, Sorrentino R, Russo G and Russo A:
5-FU targets rpL3 to induce mitochondrial apoptosis via
cystathionine-beta-synthase in colon cancer cells lacking p53.
Oncotarget. 7:50333–50348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schneider B, Nagel S, Ehrentraut S,
Kaufmann M, Meyer C, Geffers R, Drexler HG and MacLeod RA:
Neoplastic MiR-17~92 deregulation at a DNA fragility motif (SIDD).
Genes Chromosomes Cancer. 51:219–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Knudsen KN, Lindebjerg J, Nielsen BS,
Hansen TF and Sørensen FB: MicroRNA-200b is downregulated in colon
cancer budding cells. PLoS One. 12:e01785642017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng
L, Shi Y, Wang H, Yin B, Xia J and Wang Z: Down-regulation of
miR-223 reverses epithelial-mesenchymal transition in
gemcitabine-resistant pancreatic cancer cells. Oncotarget.
6:1740–1749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Chen J, Liu X, Guo Z, Sun X and
Zhang J: The real-time dynamic monitoring of microRNA function in
cholangiocarcinoma. PLoS One. 9:e994312014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akao Y, Nakagawa Y and Naoe T: Let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou Y, Wu B, Li JH, Nan G, Jiang JL and
Chen ZN: Rab22a enhances CD147 recycling and is required for lung
cancer cell migration and invasion. Exp Cell Res. 357:9–16. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Su F, Chen Y, Zhu S, Li F, Zhao S, Wu L,
Chen X and Su J: RAB22A overexpression promotes the tumor growth of
melanoma. Oncotarget. 7:71744–71753. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang D, Liu G and Wang K: miR-203 acts as
a tumor suppressor gene in osteosarcoma by regulating RAB22A. PLoS
One. 10:e01322252015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Opdam FJ, Kamps G, Croes H, van Bokhoven
H, Ginsel LA and Fransen JA: Expression of Rab small GTPases in
epithelial Caco-2 cells: Rab21 is an apically located GTP-binding
protein in polarised intestinal epithelial cells. Eur J Cell Biol.
79:308–316. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ngalame NN, Tokar EJ, Person RJ, Xu Y and
Waalkes MP: Aberrant microRNA expression likely controls RAS
oncogene activation during malignant transformation of human
prostate epithelial and stem cells by arsenic. Toxicol Sci.
138:268–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He H, Dai F, Yu L, She X, Zhao Y, Jiang J,
Chen X and Zhao S: Identification and characterization of nine
novel human small GTPases showing variable expressions in liver
cancer tissues. Gene Expr. 10:231–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mesa R, Salomón C, Roggero M, Stahl PD and
Mayorga LS: Rab22a affects the morphology and function of the
endocytic pathway. J Cell Sci. 114:4041–4049. 2001.PubMed/NCBI
|
|
39
|
Mesa R, Magadán J, Barbieri A, López C,
Stahl PD and Mayorga LS: Overexpression of Rab22a hampers the
transport between endosomes and the Golgi apparatus. Exp Cell Res.
304:339–353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kauppi M, Simonsen A, Bremnes B, Vieira A,
Callaghan J, Stenmark H and Olkkonen VM: The small GTPase Rab22
interacts with EEA1 and controls endosomal membrane trafficking. J
Cell Sci. 115:899–911. 2002.PubMed/NCBI
|
|
41
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Slattery ML, Herrick JS, Mullany LE,
Samowitz WS, Sevens JR, Sakoda L and Wolff RK: The co-regulatory
networks of tumor suppressor genes, oncogenes, and miRNAs in
colorectal cancer. Genes Chromosomes Cancer. 56:769–787. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J,
Xing R, Jin Y, Sun Z and Zheng X: MicroRNA-193b regulates
proliferation, migration and invasion in human hepatocellular
carcinoma cells. Eur J Cancer. 46:2828–2836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen J, Feilotter HE, Paré GC, Zhang X,
Pemberton JG, Garady C, Lai D, Yang X and Tron VA: MicroRNA-193b
represses cell proliferation and regulates cyclin D1 in melanoma.
Am J Pathol. 176:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fusté NP, Castelblanco E, Felip I,
Santacana M, Fernández-Hernández R, Gatius S, Pedraza N, Pallarés
J, Cemeli T, Valls J, et al: Characterization of cytoplasmic cyclin
D1 as a marker of invasiveness in cancer. Oncotarget.
7:26979–26991. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
